Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Shruti S Joshi, Trisha Singh, David E Newby et al. · Heart · 2021 · Review
Full textCC BY
Endocrinology, Diabetes and Metabolism
Filters3 filters applied
Status
Year
Readable here
Study type
7 papersQuestions on this topic
Corrected Corrected Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study
Rishi Caleyachetty, Thomas M Barber, Nuredin Ibrahim Mohammed et al. · The Lancet Diabetes & Endocrinology · 2021
Full textCC BY
Corrected Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
Stephanie M. Gruss, Kunthea Nhim, Edward Gregg et al. · Current Diabetes Reports · 2019 · Review
Full textCC BY
Corrected Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
Paul J. Connelly, E. Marie Freel, Colin Perry et al. · Hypertension · 2019 · Review
Full textCC BY
Corrected GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Andrei C. Sposito, Otávio Berwanger, Luiz Sérgio F. de Carvalho et al. · Cardiovascular Diabetology · 2018 · Review
Full textCC BY
Corrected Cardiovascular risk assessment in patients with diabetes
Marcello Casaccia Bertoluci, Viviane Zorzanelli Rocha · Diabetology & Metabolic Syndrome · 2017 · Review
Full textCC BY
Corrected Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study
Hana Kahleova, Lenka Belinova, Hana Malinska et al. · Diabetologia · 2014 · Randomised trial
Full textCC BY